top of page

enter here
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
About the study
NCT Trial Number
NCT03606538
The drug being studied
MDMA


Sponsored by
Multidisciplinary Association for Psychedelic Studies

Trial Start Date
Sep-20

About the participants
Age seeking
18 Years to 65 Years
gender
All

Primary condition of volunteers accepted
Healthy

Accepts healthy volunteers?
Yes
This study will explore the safety and tolerability of oral MDMA for MDMA assisted psychotherapy in individuals who have impaired liver function.

Locations
United States, California
University of California San Francisco
San Francisco, California, United States, 94143
Contact: Study coordinator
ClinPharmPKStudy@ucsf.edu
bottom of page